Introduction a-6(IV )). Basement membranes are thin sheet-like extracellular
The six a(IV ) chains dier considerably from each structures that form an anatomical barrier wherever other in their tissue distribution. The a-1( IV ) and cells meet connective tissue. They provide a substrate a-2(IV ) chains are found in all basement membranes, for organs and cells and relay signals important for whereas the a-3( IV ) and a-4( IV ) chains are the dierentiation and maintenance of the tissue. The co-localized in some specialized membranes, for importance of a functional basement membrane is example the GBM, lung, lens capsule, cochlea, brain, illustrated in several pathological conditions where the and testis [3] . The a-5(IV ) and a-6(IV ) chains also glomerular basement membrane (GBM) is disrupted. have a limited tissue distribution and are found, for An example is Goodpasture syndrome, where an auto-example, in skin, lens capsule, smooth muscle and immune reaction to the GBM rapidly causes life kidney. The a-5( IV ) and a-6(IV ) chains also seem to threatening disease and loss of kidney function.
be co-localized, except in the GBM which appears to lack the a-6(IV ) chain [4] . Two type IV collagen molecules are connected via
Structure of the GBM
their NCl domains and four molecules are able to interact via their 7S domains, together forming a Basement membranes are composed of several specific chicken wire-like network (Figure 1 ). In the GBM molecules such as type IV collagen, laminin, proteothere are also lateral binding sites, and the molecules glycans, entactin, and several other proteins found in are wrapped around each other forming a superstrucsmall amounts in some restricted membranes. Both ture more stable than that in other basement memlaminin and type IV collagen form large continuous branes. It has been shown that in the GBM there is a matrices. Type IV collagen has self-aggregating properseparate network composed of a-3(IV ) and a-4 (IV ) ties and forms an irreversible and stable matrix in chains that can bind to the classic a-1(IV ) and a-2 (IV ) which the other basement membrane molecules are chains via their NCl domains [5 ] . This network prointegrated. Each type IV collagen molecule is built up vides the GBM with the strength and flexibility which of three subunits, called a(IV ) chains. In the are prerequisites for its specialized functions. How the N-terminal end and in the large collagenous middle recently discovered a-5(IV ) and a-6( IV ) chains are part, the three a(IV ) chains are intertwined into a integrated in the network is still unknown. triple helical structure, like most other collagens ( Figure 1 ). In the C-terminal end each chain is folded into a separate globular structure, called the NCl Specificity of anti-GBM antibodies domain [1] . Six genetically distinct a(IV ) chains are found, designated a-1 (IV ) to a-6( IV ) ( Table 1 ) [2]. Goodpasture (GP) antibodies bind along the GBM and are seen as a linear deposition of IgG at direct On the basis of protein homology, the six a( IV ) chains are divided into an a-1(IV )-like group (comprising immunofluorescence. This pattern is explained by the tissue distribution of the a-3 (IV ) and a-4(IV ) chaina-1 (IV ) itself, a-3(IV ), and a-5 (IV )), and an a-2( IV ) Fig. 1 . Schematic representations of 1a, the type IV collagen chicken wire network; and 1b, one type IV collagen molecule with its triple helical structure and a bound GP antibody in the c-terminal part of the NCl domain. containing network. This network is also found in the The GP epitope has been found to be a cryptotope, and only very little reactivity is found against the alveolar basement membrane in the lung, indicating the clinical condition to be a renopulmonary syndrome. native hexameric structure ( Figure 2) . However, when the antigen is denatured and the hexamer dissociates When the GP antigen was first isolated, the antigen was found to be in a collagenase-resistant part of into dimers and monomers, the reactivity is increased 10-15 fold. On the other hand, if the antigen is reduced type IV collagen, the NCl domain (Figure 1 ) . If the hexameric NCl domain is dissociated into monomers and alkylated, almost all reactivity disappears, and less than 1/1000 of the binding to denatured antigen (the NCl domain from one single a(IV ) chain) and dimers, most of the reactivity is found to be directed remains [9] . There is some clear evidence that the epitope specificity of the autoantibodies involved is a against the a-3( IV ) chain [6, 7] . Anity chromatography has shown about 1% of GP patients' total IgG determinant of the disease progression rate, as shown by the patient with the a-1( IV ) antibodies. If other to be anti-type IV collagen antibodies. This is an expected figure during normal immunization. The anti-fine dierences in specificity could be identified as markers of disease and outcome in the future we will body IgG subclass pattern also indicates the occurrence of an autoimmunization process, which is characterized be able to develop new and more specific prognostic tools. by a predominance of IgGl and in some GP patients a large fraction of IgG4 as well [7 ] . Moreover about 90% of the anti-type IV collagen antibodies have been Anti-GBM antibodies in diagnosis and prognosis of found to be a-3(IV ) chain specific [8 ] . By using a the disease monoclonal antibody to the a3 (IV ) chain in an enzyme-linked immunosorbent assay ( ELISA), it was Measurement of anti-GBM antibodies is of great value found that most of the GP antibody reactivity could mainly in three clinical categories. (1 ) patients with be blocked. This indicates that there is one major acute renal failure, where post-and pre-renal causes epitope in most GP patients. seem unlikely; (2 ) patients with increasing serum creatinine concentrations together with haematuria and casts; and (3 ) patients with pulmonary haemorrhage.
Epitopes of anti-GBM antibodies
In all three categories the finding of anti-GBM antibodies confirms a definite diagnosis, and indicates a grave The normal GP antibody recognizes a conformational epitope in the NCl domain of the a-3(IV ) chain. prognosis requiring the institution of treatment without delay [10 ] . The clinical syndromes seen in conjunction Although the epitope specificity of the autoantibodies involved in GP is very restricted, exceptions nonethe-with anti-GBM antibodies can also occur in patients with ANCAs (antineutrophil cytoplasmic antibodies), less exist. We found one patient to manifest antibodies to the a-1( IV ) chain only, and none to the a-3( IV ) both PR3 (antiproteinase 3) and MPO (antimyeloperoxidase) ANCAs. Thus an indication for measurement chain. This patient did not suer from progressive disease, but from a mild and stable form of the disease. of anti-GBM antibodies is also an indication for ANCA testing. Approximately 30% of anti-GBMThe epitope for these a-1(IV ) antibodies has been localized to the last four amino acids of the a-1( IV ) positive sera also contain ANCAs, most of them with specificity for MPO. A positive ANCA-test in GP chain, with the sequence MRRT [9] . This epitope was found to be linear, in contrast to the epitope found in should not be considered to be a false positive result, but rather to be an indication of the close relationship conjunction with normal GP antibodies. Further evidence of variation in autoantibody specificity has been between vasculitis and GP. However, whether GP should be regarded as a complication of vasculitis (or found in other patients with mild disease, though this remains to be studied in greater detail.
vice versa), or whether the nature of the relationship Fig. 2 . Schematic representation of the GP cryptotope. The NCl cross-linking domain is released from the GBM by collagenase digestion as a hexameric structure. The epitope is hidden within, resulting in a low level of reactivity with GP antibodies. Once the hexamer is dissociated into its constituents, monomers and dimers, the epitope is exposed and the antibodies can react very well. If the chains are reduced, all reactivity is lost thus indicating the importance of intact disulphide bonds for the epitope.
is that the two conditions constitute manifestations of Conclusions one and the same underlying entity, is at present unclear. Having encountered families where one family As GP is a rapidly progressive disease, it is important member has GP and another has systemic vasculitis, to start therapy before tissue damage has advanced we are inclined to favour the latter interpretation. too far. The new ELISAs based on our current knowTreatment today consists of pulse-doses of methyl-ledge of the epitopes enables us to identify the patients prednisolone followed by oral prednisone and oral early, and in the future it may well be possible to cyclophosphamide combined with rapid removal of predict prognosis of the disease by studying the fine the antibodies [10 ] . Reports published hitherto provide specificity of the antibodies. no support for the view that less toxic (and thus less eective) treatment, e.g. with azathioprine or pulsed cyclophosphamide would be sucient, as it is in less References dramatic diseases (e.g. systemic lupus erythematosus). 1989; 134: 813-825 is plasmapheresis (3-4 l daily), which has been reported
